0001531984-13-000002.txt : 20131118 0001531984-13-000002.hdr.sgml : 20131118 20131118170354 ACCESSION NUMBER: 0001531984-13-000002 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20131118 DATE AS OF CHANGE: 20131118 EFFECTIVENESS DATE: 20131118 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ALDEA Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001531984 IRS NUMBER: 271252516 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-166855 FILM NUMBER: 131227624 BUSINESS ADDRESS: STREET 1: 3696 HAVEN AVE., SUITE C CITY: REDWOOD CITY STATE: CA ZIP: 94063 BUSINESS PHONE: 650 241-1600 MAIL ADDRESS: STREET 1: 3696 HAVEN AVE., SUITE C CITY: REDWOOD CITY STATE: CA ZIP: 94063 D/A 1 primary_doc.xml X0707 D/A LIVE 0001531984 ALDEA Pharmaceuticals, Inc. 3696 HAVEN AVE., SUITE C REDWOOD CITY CA CALIFORNIA 94063 650 241-1600 DELAWARE None None Corporation true Timothy Shannon c/o ALDEA Pharmaceuticals, Inc. 3696 Haven Ave., Suite C Redwood City CA CALIFORNIA 94063 Director William Yelle c/o ALDEA Pharmaceuticals, Inc. 3696 Haven Ave., Suite C Redwood City CA CALIFORNIA 94063 Executive Officer Director Wende Hutton c/o ALDEA Pharmaceuticals, Inc. 3696 Haven Ave., Suite C Redwood City CA CALIFORNIA 94063 Director Wenjin Yang c/o ALDEA Pharmaceuticals, Inc. 3696 Haven Ave., Suite C Redwood City CA CALIFORNIA 94063 Executive Officer Howard Rosen c/o ALDEA Pharmaceuticals, Inc. 3696 Haven Ave., Suite C Redwood City CA CALIFORNIA 94063 Director John Walker c/o ALDEA Pharmaceuticals, Inc. 3696 Haven Ave., Suite C Redwood City CA CALIFORNIA 94063 Director Biotechnology Decline to Disclose 06b true 0001531984-12-000003 2011-09-23 true true true true Offering of convertible promissory notes ("Notes"), the underlying shares of Series A Preferred Stock issuable upon conversion of the Notes and the underlying shares of Common Stock issuable upon conversion of Series A Preferred Stock. false 0 11483692 11380718 102974 false 6 0 0 740 false ALDEA Pharmaceuticals, Inc. /s/ William E. Yelle William E. Yelle Chief Executive Officer 2013-11-18